Alerts will be sent to your verified email
Verify Email
KABRADG
|
Kabra Drugs
|
Omkar Pharmachem
|
Vineet Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
65.41 % | 1.16 % | 6.26 % |
|
5yr average Equity Multiplier
|
-11.28 | 1.07 | 3.18 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.04 | 1.36 |
|
5yr Avg Net Profit Margin
|
0.0 | -77.87 % | 1.11 % |
|
Price to Book
|
1.14 | 2.97 | 1.98 |
|
P/E
|
0.0 | 139.13 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 60.23 Days | 89.15 Days |
|
Inventory Days
|
0.0 | 0.0 | 66.38 Days |
|
Days Receivable
|
0.0 | 60.23 Days | 80.91 Days |
|
Days Payable
|
0.0 | 12.54 Days | 81.06 Days |
|
5yr Average Interest Coverage Ratio
|
-836.53 | 3.51 | 2.14 |
|
5yr Avg ROCE
|
64.57 % | 1.5 % | 14.46 % |
|
5yr Avg Operating Profit Margin
|
0.0 | -57.26 % | 3.72 % |
|
5 yr average Debt to Equity
|
-6.16 | 0.08 | 0.69 |
|
5yr CAGR Net Profit
|
65.28 % | n/a | n/a |
|
5yr Average Return on Assets
|
-21.32 % | 1.11 % | 1.2 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 0.03 % | 35.85 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kabra Drugs
|
Omkar Pharmachem
|
Vineet Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|